References: Pharmacological management of behavioural and psychological symptoms of dementia
Anstey KJ, Peters R. Dementia prevention. NHMRC partnership centre for dealing with cognitive and related functional decline in older people. Sydney: National Health and Medical Research Council (NHMRC); 2019. https://cdpc.sydney.edu.au/research/care-service-pathways/
Bachoud-Levi AC, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, et al. International guidelines for the treatment of Huntington’s disease. Front Neurol 2019;10:710. https://www.ncbi.nlm.nih.gov/pubmed/31333565
Baillon SF, Narayana U, Luxenberg JS, Clifton AV. Valproate preparations for agitation in dementia. Cochrane Database Syst Rev 2018;10:CD003945. https://www.ncbi.nlm.nih.gov/pubmed/30293233
Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician 2018;64(1):17–27. https://www.ncbi.nlm.nih.gov/pubmed/29358245
Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I. Use of benzodiazepines in Alzheimer’s disease: A systematic review of literature. Int J Neuropsychopharmacol 2015;18(10):pyv055. https://www.ncbi.nlm.nih.gov/pubmed/25991652
Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B. Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis. PLoS One 2017;12(4):e0174730. https://www.ncbi.nlm.nih.gov/pubmed/28448593
Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ 2015;350:h369. https://www.ncbi.nlm.nih.gov/pubmed/25731881
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet 2017;390(10113):2673–734. https://www.ncbi.nlm.nih.gov/pubmed/28735855
Ma H, Huang Y, Cong Z, Wang Y, Jiang W, Gao S, et al. The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials. J Alzheimers Dis 2014;42(3):915–37. https://www.ncbi.nlm.nih.gov/pubmed/25024323
Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry 2015;72(5):438–45. https://www.ncbi.nlm.nih.gov/pubmed/25786075
National Institute for Health and Care Excellence (NICE). Dementia: assessment, management and support for people living with dementia and their carers (NG97). London: NICE; 2018. https://www.nice.org.uk/guidance/ng97
Palmaro A, Dupouy J, Lapeyre-Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 2015;25(10):1566–77. https://www.ncbi.nlm.nih.gov/pubmed/26256008
Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA 2014;311(7):682–91. https://www.ncbi.nlm.nih.gov/pubmed/24549548
Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, et al. The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry 2016;173(5):543–6. https://www.ncbi.nlm.nih.gov/pubmed/27133416
Rolinski M, Fox C, Maidment I, McShane R. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev 2012;(3):CD006504. https://www.ncbi.nlm.nih.gov/pubmed/22419314
Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P. Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev 2011;(2):CD008191. https://www.ncbi.nlm.nih.gov/pubmed/21328305
Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, et al. Pharmacological management of lewy body dementia: A systematic review and meta-analysis. Am J Psychiatry 2015;172(8):731–42. https://www.ncbi.nlm.nih.gov/pubmed/26085043
Tampi RR, Tampi DJ. Efficacy and tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia: a systematic review of randomized controlled trials. Am J Alzheimers Dis Other Demen 2014;29(7):565–74. https://www.ncbi.nlm.nih.gov/pubmed/25551131
Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Ther Adv Chronic Dis 2016;7(5):229–45. https://www.ncbi.nlm.nih.gov/pubmed/27583123
Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol 2019. https://www.ncbi.nlm.nih.gov/pubmed/31519472
Van Leeuwen E, Petrovic M, van Driel ML, De Sutter AIM, Vander Stichele R, Declercq T, Christiaens T. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD007726. DOI: 10.1002/14651858.CD007726.pub3
Wang J, Yu JT, Wang HF, Meng XF, Wang C, Tan CC, et al. Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2015;86(1):101–9. https://www.ncbi.nlm.nih.gov/pubmed/24876182
Watt JA, Goodarzi Z, Veroniki AA, Nincic V, Khan PA, Ghassemi M, et al. Comparative efficacy of interventions for aggressive and agitated behaviors in dementia: A systematic review and network meta-analysis. Ann Intern Med 2019;171(9):633–42. https://www.ncbi.nlm.nih.gov/pubmed/31610547
Westaway K, Blacker N, Shute R, Allin R, Elgebaly Z, Frank O, et al. Combination psychotropic medicine use in older adults and risk of hip fracture. Aust Prescr 2019;42(3):93–6. https://www.ncbi.nlm.nih.gov/pubmed/31363307
Yunusa I, Alsumali A, Garba AE, Regestein QR, Eguale T. Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: A network meta-analysis. JAMA Netw Open 2019;2(3):e190828. https://www.ncbi.nlm.nih.gov/pubmed/30901041
